project id: TCGA-SKCM; case submitter id: TCGA-FS-A4F9; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.25; rna integrity number: 8.6; age at index: 80; days to birth: -29324; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1931; age at diagnosis: 29324; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1035.0; icd 10 code: C77.9; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph node, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 625; initial weight: 110.0; oct embedded: false; preservation method: Unknown; sample id: 94eb86f9-8c07-4a0f-b24f-86ca64f2e533; sample submitter id: TCGA-FS-A4F9-06A; portion id: 5b52e8c6-92de-4fb0-a3e8-3134a0a3bbd9; portion submitter id: TCGA-FS-A4F9-06A-11; slide id: 80147501-0444-4862-ae49-fd1626ac5e8f; slide submitter id: TCGA-FS-A4F9-06A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 90.0; section location: TOP;